Real-Time Adverse Drug Reaction Surveillance Platform
Automated ADR Signal Detection for Real-Time Pharmacovigilance
Lifebit R.E.A.L. helps drug safety teams look for adverse drug reaction signals in real-world data, analyzed where the data is stored.


Lifebit R.E.A.L.
Real-Time Adverse Drug Reaction Surveillance Platform. Lifebit R.E.A.L. helps drug safety teams look for adverse drug reaction signals in real-world data, analyzed where the data is stored.

- 🧠 AI-Driven, Real-Time ADR Surveillance
Smarter pharmacovigilance for public health and safety
Lifebit R.E.A.L. helps teams analyze real-world data to detect adverse drug reactions (ADRs), surface trends, and prioritize risks.
- Reduce manual review
- Reduce costs
- Prioritize security
- Safeguard patients
- Why Lifebit R.E.A.L.?
Your trusted partner for real-time pharmacovigilance
Built on the Lifebit platform that governments, pharma, and biobanks use to analyze sensitive health data.
AI-powered signal detection at scale
Look for emerging adverse drug reaction (ADR) signals with AI-assisted analysis of structured and unstructured data, so reviewers spend less time on manual searches.
Built for security and compliance
Built on FedRAMP Moderate and NIST 800-53 controls and aligned with HIPAA and GDPR, Lifebit R.E.A.L. runs inside secure environments, so safety analysis happens where the data is stored.
Trusted by governments and global leaders
Lifebit R.E.A.L. runs on the Lifebit platform, trusted by governments, pharma, and biobanks, so drug safety signals are analyzed where the data lives.
Impact
Accelerate signal detection and optimize post-market safety monitoring with Lifebit R.E.A.L.™
Proven Platform
30+
countries where governments, pharma, and biobanks use the Lifebit platform that R.E.A.L. is built on.
AI Monitoring
Since 2021
Boehringer Ingelheim has used Lifebit AI to scan scientific and open sources for animal disease outbreaks.
Traceable Results
Full
audit trail of every query, export, and report, so each finding can be traced and reproduced.
How it Works.
We’ve outlined how Lifebit R.E.A.L.™ helps organizations unlock real-time adverse event insights from complex, distributed data—securely and at scale.
Log in and define your safety focus.
Start by accessing the Lifebit R.E.A.L.™ platform. Simply specify the drug(s), therapeutic class, population, or event type you wish to monitor. The platform uses these choices to focus monitoring on what matters to you.

Track emerging risks, instantly.
The platform scans the data sources you connect, such as clinical notes, public health records, and spontaneous reports, to surface possible adverse drug reactions (ADRs) across populations and regions.

Detect ADR signals in real-time
Lifebit monitors the sources you connect, from EHRs and safety databases to published literature and news, for emerging adverse drug reactions (ADRs).

Visualize activity and signal clusters
Interactive dashboards display geographic case maps, spike alerts, and granular case-level data with intuitive filters by drug, demographic, region, or clinical outcome—enabling instant signal tracking, risk assessment, and proactive action planning.

Prioritize and triage emerging ADRs
AI models rank signals by severity, frequency, and novelty—so you know what matters most. Drill into timelines, supporting evidence, and affected populations to support faster decisions.

Generate reports and share insights
Export datasets, download trend visualizations, and create summary PDFs. Lifebit R.E.A.L.™ supports internal safety reviews—backed by full data lineage and audit trails.

Frequently asked questions
What is Lifebit R.E.A.L.™?
Lifebit R.E.A.L.™ (Real-time Evidence & Analytics Layer) is a cloud-native AI platform designed to help teams detect and evaluate adverse drug reaction (ADR) signals in real-world data. It automates surveillance and analytics workflows, so safety teams can review signals sooner.
How does Lifebit R.E.A.L.™ support ADR surveillance?
R.E.A.L.™ continuously monitors diverse data sources, including clinical records and external media, to identify safety signals. It surfaces geographic spikes, case clusters, and risk trends via intuitive dashboards and alerts.
Who is Lifebit R.E.A.L.™ designed for?
It’s built for regulatory agencies, public health authorities, and life sciences organizations that require fast, scalable insights into drug safety and therapeutic risk.
What data sources does R.E.A.L.™ use for ADR detection?
R.E.A.L.™ integrates structured data (e.g., EHR, claims) and unstructured content (e.g., clinical notes, online reports) across federated environments—ensuring comprehensive and compliant analysis.
Can I use my own models or tools within the platform?
Yes. Lifebit R.E.A.L.™ supports full-code access, integration with custom AI/ML models, and compatibility with platforms like SageMaker and HuggingFace.
How quickly can Lifebit R.E.A.L.™ be deployed?
R.E.A.L.™ is deployed inside your own secure cloud environment. The timeline depends on the data sources you connect, and our team will give you a plan.
Is Lifebit R.E.A.L.™ compliant with data protection standards?
Yes. The platform runs on FedRAMP Moderate (NIST 800-53) controls, is aligned with HIPAA and GDPR, and uses a federated architecture that keeps sensitive data secure and in place.
How does Lifebit R.E.A.L.™ differ from traditional pharmacovigilance tools?
Unlike legacy systems, R.E.A.L.™ combines AI-powered automation, real-time monitoring, and federated compute to deliver faster insights without compromising privacy or scale.
Work Together
Great work doesn’t happen alone. Let our experts show you how our product suite eliminates silos and unifies strategy.
Talk to an expert for enterprise service solutions
Lifebit R.E.A.L. helps drug safety teams look for adverse drug reaction signals in real-world data, analyzed where the data is stored.
Premium onboarding & workspace setup
- Enterprise-grade access control & export review
Configurable policies & role-based approvals
- 24/7 compliance & platform support





